Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Laser zaps prostate tumors with precision in early trial

NCT ID NCT02600156

First seen Jan 10, 2026 · Last updated May 01, 2026 · Updated 12 times

Summary

This study tested a new way to treat low-risk prostate cancer using MRI-guided laser ablation. Doctors used heat from a laser to destroy cancer cells while monitoring the temperature in real time. Seven men with early-stage prostate cancer took part. The goal was to see if the procedure is safe and effective, with fewer side effects like incontinence or impotence.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE ADENOCARCINOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Mayo Clinic in Minnesota

    Rochester, Minnesota, 55905, United States

Conditions

Explore the condition pages connected to this study.